International Stem Cell Corp. ISCO Company Overview

New Post Public Reply Private Reply Replies (0) Message Board

Sep 15, 2013 at 5:38 AM

International Stem Cell Corp. ISCO Company Overview

Stock Message Board http://investorshangout.com/search?q=ISCO&...mp;yt1=Go!

International Stem Cell Corp. ISCO Current Price and Quotes
Last Price 0.1478
Previous Close 0.1515 Open 0.1515
Daily Range 0.1515 - 0.1478 52wk Range 0.41 - 0.13
Volume 230,272 Dividend N/A
Average Vol (3m) 433,226 Yield N/A
International Stem Cell Corp. ISCO
Company Information

5950 Priestly Drive
Carlsbad, CA 92008

Website: http://www.internationalstemcell.com
Phone: 760-940-6383
Email: ir@intlstemcell.com
Find us on:

International Stem Cell Corp. ISCO
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell...

International Stem Cell Corp. ISCO
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001355790
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Oct 13, 2011
Incorporated In: DE, USA
Year of Inc. Not Available
Employees 41 a/o Mar 31, 2012
Company Officers/Contacts

Andrey Semechkin CEO
Jay Novak CFO
Simon Craw EVP, Dev.
Investor Relations IR
Company Directors

Andrey Semechkin Co-Chairman
Kenneth Aldrich
Company Notes

Formerly=BTHC III, Inc. until 1-07
Service Providers

Auditor/Accountant
Mayer Hoffman McCann, P.C. (CA)
2301 Dupont Drive
Suite 200
Irvine, CA, 92612
United States

Legal Counsel
Not Available
Investor Relations Firm
QualityStocks.com
3370 N. Hayden Rd.
Scottsdale, AZ, 85251
United States

International Stem Cell Corp. ISCO
ISCO Security Details

Share Structure

Market Value1 $19,596,922 a/o Sep 13, 2013
Shares Outstanding 132,590,815 a/o Aug 02, 2013
Float Not Available
Authorized Shares 300,000,000 a/o May 30, 2012
Par Value 0.001
Shareholders

Shareholders of Record 647 a/o Mar 26, 2013
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) Nov 21, 2006 Nov 20, 2006 Nov 20, 2006
Security Notes

Capital Change=shs increased by 4.42 for 1 split. Ex-date=11/21/2006. Rec date=11/20/2006. Pay date=11/20/2006.
Short Selling Data

Short Interest 58,344 (422%)
Aug 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)

Securities Transfer Corp

International Stem Cell Corp. ISCO Recent News

Sept 9, 2013 International Stem Cell Corporation Advances Parkinson's Disease Program Towards IND Stage
Aug 28, 2013 International Stem Cell Corporation to Present at Rodman & Renshaw 15th Annual Global Investment Conference September 8th to 10th
Aug 21, 2013 International Stem Cell Corporation Enters Into Clinical Research Agreement for Parkinson's Disease Program
Aug 8, 2013 International Stem Cell Corporation Announces Second Quarter 2013 Financial Results
Aug 6, 2013 Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on International Stem Cell Corporation
Aug 2, 2013 International Stem Cell Corporation to Host Second Quarter 2013 Financial Results Conference Call at 11:00 a.m. ET on Friday, August 9, 2013
Jul 19, 2013 International Stem Cell Corporation Announces Pricing of Public Offering
Jun 27, 2013 International Stem Cell Corporation to Present Data From Its Parkinson's Disease Program at Society for Neuroscience Annual Meeting

International Stem Cell Corp. ISCO Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 4,567 4,532 1,568 1,121
Cost of Revenue 1,272 1,618 725 790
Gross Profit 3,295 2,914 843 331
Operating Expenses

Research and Development 3,599 4,434 3,374 2,164
Sales, General and Admin. 9,509 9,835 7,931 5,366
Non-Recurring Items - - - -
Other - - - -
Operating Income (9,813) (11,355) (10,462) (7,199)
Income From Continuing Operations

Add'l Income/Expense Items (20) 2,184 (2,247) (1,211)
Earnings Before Interest and Tax (9,833) (9,171) (12,709) (8,410)
Interest Expense - - 14 95
Earnings Before Tax (9,833) (9,171) (12,723) (8,504)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (9,833) (9,171) (12,723) (8,504)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (9,833) (9,171) (12,723) (8,504)
Preferred Stock and Other Adjustments (1,504) (430) (1,561) (4,396)
Net Income Applicable to Common Shareholders (11,337) (9,601) (14,284) (12,900)

ISCO International Stem Cell Corp. Research DD Guide

ISCO International Stem Cell Corp. Stock Message Board http://investorshangout.com/search?q=ISCO&...mp;yt0=Go!
ISCO International Stem Cell Corp. Stock Quote http://www.otcmarkets.com/stock/ISCO/quote
ISCO International Stem Cell Corp. Stock Chart http://www.otcmarkets.com/stock/ISCO/chart
ISCO International Stem Cell Corp. Company Info http://www.otcmarkets.com/stock/ISCO/company-info
ISCO International Stem Cell Corp. Recent News http://www.otcmarkets.com/stock/ISCO/news
ISCO International Stem Cell Corp. Financials http://www.otcmarkets.com/stock/ISCO/financials
ISCO International Stem Cell Corp. Filings and Disclosure http://www.otcmarkets.com/stock/ISCO/filings
ISCO International Stem Cell Corp. Short Sales http://www.otcmarkets.com/stock/ISCO/short-sales
ISCO International Stem Cell Corp. Insider Disclosure http://www.otcmarkets.com/stock/ISCO/insider-transactions
ISCO International Stem Cell Corp. Research Reports http://www.otcmarkets.com/stock/ISCO/research
ISCO International Stem Cell Corp. Summary http://finance.yahoo.com/q?s=ISCO
ISCO International Stem Cell Corp. Historical Prices http://finance.yahoo.com/q/hp?s=ISCO+Historical+Prices
ISCO International Stem Cell Corp. Interactive Chart http://finance.yahoo.com/echarts?s=ISCO
ISCO International Stem Cell Corp. Basic Chart http://finance.yahoo.com/q/bc?s=ISCO+Basic+Chart
ISCO International Stem Cell Corp. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ISCO+Basic+Tech.+Analysis
ISCO International Stem Cell Corp. Headlines http://finance.yahoo.com/q/h?s=ISCO+Headlines
ISCO International Stem Cell Corp. Press Releases http://finance.yahoo.com/q/p?s=ISCO+Press+Releases
ISCO International Stem Cell Corp. Company Profile http://finance.yahoo.com/q/pr?s=ISCO+Profile
ISCO International Stem Cell Corp. Key Statistics http://finance.yahoo.com/q/ks?s=ISCO+Key+Statistics
ISCO International Stem Cell Corp. Industry http://finance.yahoo.com/q/in?s=ISCO+Industry
ISCO International Stem Cell Corp. Major Holders http://finance.yahoo.com/q/mh?s=ISCO+Major+Holders
ISCO International Stem Cell Corp. Insider Transactions http://finance.yahoo.com/q/it?s=ISCO+Insider+Transactions
ISCO International Stem Cell Corp. Insider Roster http://finance.yahoo.com/q/ir?s=ISCO+Insider+Roster
ISCO International Stem Cell Corp. Income Statement http://finance.yahoo.com/q/is?s=ISCO
ISCO International Stem Cell Corp. Balance Sheet http://finance.yahoo.com/q/bs?s=ISCO
ISCO International Stem Cell Corp. Cash Flow http://finance.yahoo.com/q/cf?s=ISCO+Cash+Flow&annual
ISCO International Stem Cell Corp. Nasdaq http://www.nasdaq.com/symbol/ISCO
ISCO International Stem Cell Corp. Market Watch http://www.marketwatch.com/investing/stock/ISCO
ISCO International Stem Cell Corp. Bloomberg http://www.bloomberg.com/quote/ISCO:US
ISCO International Stem Cell Corp. Morningstar http://quotes.morningstar.com/stock/s?t=ISCO
ISCO International Stem Cell Corp. Bussinessweek http://investing.businessweek.com/research/st...icker=ISCO
ISCO International Stem Cell Corp. Barchart http://www.barchart.com/quotes/stocks/ISCO
ISCO International Stem Cell Corp. OTC Short Report http://otcshortreport.com/index.php?index=ISCO
ISCO International Stem Cell Corp. Investopedia http://www.investopedia.com/markets/stocks/ISCO/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jiangxi Dialogues: Youths Forge Global Ties in 2026

Bringing Global Youth to the Table In the heart of Jiangxi, China, young minds from across the globe gathered not just to chat but to shape the future. A bunch who only a decade ago might have been ignored in such circles are now leading discussions, and they’ve kicked off their powwow on September 22, 2026, with a bang in Nanchang. What’s the Agenda? Imagine more...

ODL’s Impact Door System Wins 2026 Editors' Pick

Award-Winning Entry: ODL's Latest Triumph In a world where first impressions count, ODL, Inc. sure knows how to leave a mark. Their Impact Rated Fiberglass Entry System with Keystone Frame Technology snagged a notable spot in the 2026 Best of Products Awards by Architect's Newspaper. Let me tell you, in the building biz, accolades like these are no small potatoes. To get...

FlyQuest & Von Dutch Link Gaming, Fashion Again

Breaking Down Barriers in Fashion and Gaming In a world full of unlikely matches, the partnership between FlyQuest and Von Dutch is one that's catching serious eyeballs. FlyQuest, an esports powerhouse, has teamed up once more with the iconic fashion brand Von Dutch to launch "The Workman Collection." This ain't just about slapping logos on t-shirts and calling it a...

Kexing Biopharm Expands Global Reach at CPHI Milan

Kexing Biopharm's Showstopper Moment in Milan Call it a strategic blowout or just audacious timing—Kexing Biopharm's move at the CPHI Milan 2026 has painted a clear picture. From October 6th to 8th, Milan was the stage where Kexing rolled out its showcase, bragging about a pipeline that screams innovation and possibility. And let’s be honest, their timing couldn’t...

NOARK: Powering Data Centers with Global-Local Approach

The High-Stakes Race for Data Center Power These days, if you're not talking about data centers, you're probably a step behind the curve. AI's explosive growth is pushing data center developments across North America like never before. Larger campuses, hefty power densities—it's all happening at a pace that's got everyone scrambling. For folks like NOARK Electric, this...

Zenni and Chase Stokes Foster Student Wellbeing in NYC

Picture this: near 300 high schoolers milling around, glancing through shiny new glasses from the Zenni x Chase Stokes collection. In the heart of New York City, these kids are getting a double-dose of care that's all too rare—free vision screenings paired with mental health support. It's the kind of collaboration that shows you what's possible when a company, an actor,...

Navigating Career Growth Beyond Job Titles at Webinar

Hasn't it ever struck you that job titles often fence people in like some unwanted corral, keeping potential tightly leashed? Well, here's something that might shake up your thoughts a tad. University of Phoenix is teeing up a webinar titled "Beyond The Job Title: Finding Purpose and Recognizing the Value You Bring." Scheduled for October 15, 2026, this is all about...

Haag-Streit Debuts Innovative Octopus 910 Perimeter at AAO

Now here's something that'll tickle your ophthalmologist's fancy—Haag-Streit USA has rolled out the Octopus 910, a slick piece of kit set to shake up visual field testing for glaucoma management. This time, they're getting in front of the competition, unveiling it at the Association for Research in Vision and Ophthalmology's 2026 shindig in New Orleans. With this new...

Greenberg Traurig Nabs Major Award for Sukuk Deal

Legal brands winning awards might seem like just another day in the office, but when a firm like Greenberg Traurig snags the Impact Deal of the Year at the IFLR Middle East Awards, it deserves more than just a shrug. We're talking about a serious feather in the cap for their Capital Markets team, who played a key role in launching Binghatti's hefty USD 1.5 billion Sukuk...

Chianti Classico Showcases 2027 Vintages in Florence

A Grand Reunion of the Black Rooster You're not just sipping wine at a garden party—you're diving into a historic event. Come March 1-2, 2027, Florence will again host the much-anticipated Chianti Classico Collection, uniting over 200 eager producers under the iconic vaults of Stazione Leopolda. This isn't just another stop on the wine circuit; it's a pilgrimage to the...